{"id":99330,"date":"2004-11-08T06:00:00","date_gmt":"2004-11-08T05:00:00","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/marka-magvit-w-portfolio-peppermint-medical\/"},"modified":"2004-11-08T06:00:00","modified_gmt":"2004-11-08T05:00:00","slug":"marka-magvit-w-portfolio-peppermint-medical","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/marka-magvit-w-portfolio-peppermint-medical.html","title":{"rendered":"Marka Magvit w portfolio Peppermint Medical"},"content":{"rendered":"<p><P>Dzia\u0142ania ATL, kt\u00f3re trwaj\u0105 od pa\u017adziernika obejmuj\u0105 reklam\u0119 w radiu i w prasie.<\/P><br \/>\n<P>Peppermint Medical jako cz\u0119\u015b\u0107 medyczna agencji Peppermint specjalizuje si\u0119 w budowaniu strategii komunikacji dla bran\u017cy medycznej i realizacji reklam BTL i ATL dla produkt\u00f3w farmaceutycznych OTC i Rx oraz us\u0142ug medycznych.<\/P><br \/>\n<P>W Peppermint Medical opr\u00f3cz zespo\u0142\u00f3w strategicznych, kreatywnych, produkcyjnych, prawnych, obs\u0142ugi klienta funkcjonuje zesp\u00f3\u0142 medyczny, kt\u00f3ry posiada do\u015bwiadczenie w pozycjonowaniu marek farmaceutycznych i wiedz\u0119 medyczn\u0105.<\/P><br \/>\n<P>Peppermint Medical tworzy strategie komunikacji i realizuje reklamy BTL i ATL w oparciu o insight pacjenta, lekarza, farmaceuty, wiedz\u0119 medyczn\u0105 i dobre rozumienie funkcjonowania rynku farmaceutycznego.<\/P><\/p>\n","protected":false},"excerpt":{"rendered":"Peppermint Medical prowadzi dzia\u0142ania marketingowe BTL i ATL dla marki Magvit B6 GlaxoSmithKline. Peppermint Medical wygra\u0142 we wrze\u015bniu przetarg rozwijaj\u0105c strategi\u0119 komunikacji i przygotowuj\u0105c kreacj\u0119.","protected":false},"author":1,"featured_media":99331,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[],"class_list":{"0":"post-99330","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atl","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/99330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=99330"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/99330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/99331"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=99330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=99330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=99330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}